Montelukast Prescribing at STOCK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
248
Total Quantity
6,944
NHS Cost
£398
vs National Avg
-63.8%
STOCK SURGERY prescribed 248 items of Montelukast over the last 12 months at a cost of £398 to the NHS. This is 63.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
17
Jul 2026
19
Jul 2026
25
Jul 2026
15
Jul 2026
19
Jul 2026
23
Jul 2026
25
Jul 2026
20
Jul 2026
26
Jul 2026
19
Jul 2026
21
Jul 2026
19
Prescribing Details
| Total Items | 248 |
|---|---|
| Total Quantity | 6,944 |
| Total NHS Cost | £398 |
| Presentations | 4 different forms |
| vs National Average | -63.8% |
Montelukast Prescribing Comparison
| This practice | 248 items |
|---|---|
| National average per practice | 685 items |
| Difference | -63.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.